Literature DB >> 10454989

Antisense transgenics in animals.

R P Erickson1.   

Abstract

Antisense transgenesis provides a methodology for ablating gene expression in targeted tissues through the use of tissue-specific or controllable promoters. The two major features to be considered in the design of a construct for injection are (1) the target sequence and (2) the promoter to be used. Information is provided to help the investigator make decisions in these regards. The standard methodology of making transgenics is not replicated but some hints as how best to use a transgenic facility are provided. An overview of methods for studying transgene expression and target gene suppression is given. In summary, antisense transgenesis may provide a more readily achievable method for tissue-specific ablation of a gene's function than controllable knockouts provide. Copyright 1999 Academic Press.

Mesh:

Substances:

Year:  1999        PMID: 10454989     DOI: 10.1006/meth.1999.0788

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  3 in total

Review 1.  Genetically engineered mice and their use in aging research.

Authors:  J K Andersen
Journal:  Mol Biotechnol       Date:  2001-09       Impact factor: 2.695

2.  Reversible cardiac fibrosis and heart failure induced by conditional expression of an antisense mRNA of the mineralocorticoid receptor in cardiomyocytes.

Authors:  Ahmed T Beggah; Brigitte Escoubet; Stefania Puttini; Stephane Cailmail; Vanessa Delage; Antoine Ouvrard-Pascaud; Brigitte Bocchi; Michel Peuchmaur; Claude Delcayre; Nicolette Farman; Frederic Jaisser
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

3.  Altering cellular signaling pathways enhance gene silencing activity of shRNA, shRNA.ribozyme, and shRNA.antisense in neuroblastoma cells.

Authors:  Piruz Nahreini; Amy J Hanson; Cynthia P Andreatta; William T Koustas; Kedar N Prasad
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.